Organ-specific radiation dose rates and effective dose rates during percutaneous nephrolithotomy

Journal of Endourology

Volumn 26, Issue 5, 2012, Pages 439-443

  Lipkin, Michael E ^a   Mancini, John G ^a   Toncheva, Greta ^a   Wang, Agnes J ^a   Anderson Evans, Colin ^a   Simmons, W Neal ^b   Ferrandino, Michael N ^a   Yoshizumi, Terry T ^a   Preminger, Glenn M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Duke University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METAL OXIDE;

CLINICAL ARTICLE; DOSIMETRY; FLUOROSCOPY; HUMAN; MALE; PATIENT POSITIONING; PERCUTANEOUS NEPHROLITHOTOMY; PHANTOM; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION EXPOSURE; REVIEW; SEMICONDUCTOR; SKIN;

ADULT; ANTHROPOMETRY; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; INTRAOPERATIVE CARE; MALE; NEPHROSTOMY, PERCUTANEOUS; ORGAN SPECIFICITY; PHANTOMS, IMAGING;

EID: 84860442028     PISSN: 08927790     EISSN: 1557900X     Source Type: Journal    
DOI: 10.1089/end.2011.0178     Document Type: Review

References (16)

1. Hurwitz LM, Yoshizumi TT, Goodman PC, et al. Effective dose determination using an anthropomorphic phantom and metal oxide semiconductor field effect transistor technology for clinical adult body multidetector array computed tomography protocols. J Comput Assist Tomogr 2007;31: 544-549.
2. The 2007 Recommendations of the International Commission on Radiological Protection. ICRP Publication 103. Ann ICRP 2007;37:1-332.
3. Le Heron JC. Estimation of effective dose to the patient during medical x-ray examinations from measurements of the dose-Area product. Phys Med Biol 1992;37:2117-2126.
4. Mettler FA Jr, Thomadsen BR, Bhargavan M, et al. Medical radiation exposure in the U.S. in 2006: Preliminary results. Health Phys 2008;95:502-507.
5. Brenner DJ, Hall EJ. Computed tomography-An increasing source of radiation exposure. N Engl J Med 2007;357:2277-2284.
6. Berrington de González A, Mahesh M, Kim KP, et al. Projected cancer risks from computed tomographic scans performed in the United States in 2007. Arch Intern Med 2009;169:2071-2077.
7. Ferrandino MN, Bagrodia A, Pierre SA, et al. Radiation exposure in the acute and short-Term management of urolithiasis at 2 academic centers. J Urol 2009;181:668-673.
8. Morris DS, Wei JT, Taub DA, et al. Temporal trends in the use of percutaneous nephrolithotomy. J Urol 2006;175:1731-1736.
9. Mancini JG, Raymundo EM, Lipkin M, et al. Factors affecting patient radiation exposure during percutaneous nephrolithotomy. J Urol 2010;184:2373-2377.
10. Tepeler A, Binbay M, Yuruk E, et al. Factors affecting the fluoroscopic screening time during percutaneous nephrolithotomy. J Endourol 2009;23:1825-1829.
11. Groves AM, Owen KE, Courtney HM, et al. 16-detector multislice CT: dosimetry estimation by TLD measurement compared with Monte Carlo simulation. Br J Radiol 2004; 77:662-665.
12. Jaco JW, Miller DL. Measuring and monitoring radiation dose during fluoroscopically guided procedures. Tech Vasc Interv Radiol 2010;13:188-193.
13. Preston DL, Shimizu Y, Pierce DA, et al. Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997. Radiat Res 2003; 160:381-407.
14. Balter S, Hopewell JW, Miller DL, et al. Fluoroscopically guided interventional procedures: A review of radiation effects on patients' skin and hair. Radiology 2010;254:326-341.
15. Lipkin M, Mancini J, Raymundo E, et al. Organ specific radiation dose rate for percutaneous nephrolithotomy in a validated model. J Endourol 2010;24(S1):A78.
16. Taylor EN, Stampfer MJ, Curhan G. Obesity, weight gain, and the risk of kidney stones. JAMA 2005;293:455-462.